| Ask4articles.info |
|
|
![]() |
Clinical Question: Does antibiotic ...Clinical Question: Does antibiotic therapy hinder cardiovascular events in patients with heart disease? Setting: Various (meta-analysis) application of mind Design: Meta-analysis (randomized controlled trials) Synopsis: The authors of this meta-analysis combined the inferences of nine randomized studies enrolling more than 11000 participants (mostly men) They identified these studies by means of searching MEDLINE and references of review articles. They included in their analysis merely articles written in English. The authors may have missed research findings: it is preferable to diocese a search of at least sum of two units databases, the inclusion of research in all languages, and a search for unpublished research. Their timing also may be poor: five large studies examining the part of antibiotic therapy in the prevention of cardiovascular circumstances in patients with heart disease generally are being conducted. The studies the authors used recorded patients with known coronary heart disease who were treated with antibiotics regardless of the appearance of Chlamydia pneumoniae. In the various studies, patients were treated with placebo or a macrolide antibiotic--azithromycin, roxithromycin, or clarithromycin--for seven to 90 days. The results to be prevented were acute myocardial infarction, unstable angina, or unforeseen death. Individually, only one of the nine studies erect a benefit to treatment; when combined, there was no statistically significant reduction in the combined consequences or in mortality rates. Bottom Line: In nine studies enrolling more than 11000 participants with coronary heart disease, antibiotic treatment with a macrolide did not decrease the likelihood of death or a coronary termination More studies currently are being bearinged in specific populations. (Level of Evidence: 1a) contemplation Reference: Wells BJ, et al. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controll trials. Arch Intern M October 25 2004;164:2156-61 Used with permission from Shaughnessy AF. Antibiotics ineffective in preventing 2nd heart attack. Accessed online December 28 2004 at: http://www.InfoPOEMs.com. COPYRIGHT 2005 American Academy of Family Physicians Rechtschutz - Raucher Kneipen |
![]() |
Other Articles
-Feb. 1-8: Medicine of div...-Clinical Quiz questions a... -Jun. 18-21, 2003: WONCA r... -The surge of interest in ... -What kind of diet will he... -Oct. 1-5, 2003: New Orlea... -What does it take to lose... -Isolating persons infecte... -On page 77 of this issue,... -What should I eat when tr... -The U.S. Surgeon General'... -Echinacea is the name of ... -The Centers for Medicare ... -What is echinacea? Echi... -The navicular bone of the... -Technology-intensive chil... -A peer-reviewed, Web-base... -The 2003 Recommended Chil... -Diabetic patients who req... -The dryness of the skin's... -* Essure System. The U.S.... -The Centers for Disease C... -* Oats: you gotta love 'e... -The administration of inf... -Alabama Feb. 24-25: Spi... -The Cochrane Abstract bel... -The Department of Health ... -Clinical Quiz questions a... -Patients with hypertensio... -Jan. 17-19: Headache now ... -Case Scenario Yellowing... -Jun. 20-27: 7th diabetes ... -Monday We shouldn't tre... -Results of a new study by... -* Commit Lozenge. The Com... -A new report by the Insti... -This is one in a series e... -The Committee on Practice... -A new booklet of guidelin... -What is histoplasmosis? ... -Approximately 192,200 wom... -Monday "We promised her... -Histoplasmosis is an ende... -What is breast-conserving... -As someone who has had a ... -The Recommended Adult Imm... -Alaska May 16-18: Pract... -* Fashion could be harmfu... -Although celiac disease w... -Jan. 4-17: Communication ... -In a recent column, I men... -The interrupted horizonta... -Jun. 20-27: 7th diabetes ... -Jun. 18-21, 2003: WONCA r... -The article "Prealbumin: ... -Oct. 1-5, 2003: New Orlea... -The Department of Health ... -The Minnesota Health Tech... -The Agency for Healthcare... |
| . |